GLP1R and obesity due to melanocortin 4 receptor deficiency: Meanwhile, the recent observation that previous use of anti-obesity medication is associated with poorer weight loss outcomes with semaglutide further expands our knowledge that GLP-1 RAs produce poor weight loss (Ghusn et al., 2024).